SARS-CoV-2 vaccine
SARS-CoV-2 vaccine is a biological therapy with 11 clinical trials. Currently 3 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
3
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
Vaccine Responses in Cancer
Antibody Detection of Vaccine-Induced Secretory Effects
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed
Clinical Trials (11)
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
Vaccine Responses in Cancer
Antibody Detection of Vaccine-Induced Secretory Effects
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)
Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults
Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease
COVID-19 Vaccines Associated Malaise
Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI
Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases
All 11 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 11